Cardiology pp 193-207 | Cite as

Clinical Efficiency and Side-Effects of Old and New Antiarrhythmic Drugs

  • Erik Sandϕe
  • Ellen Damgaard Andersen
  • Jens Damgaard Andersen
  • Bjarne Sigurd


The number of antiarrhythmic drugs has increased greatly during the last three decades. From the triad of digitalis, quinidine and procainamide in 1951 to now a multitude of drugs. The purpose of the present paper is to assess the therapeutical potentials of this large armory of drugs. Focus will be on long-term prophylaxis of symptomatic paroxysmal tachycardia and fibrillation with a few comments on the treatment of ventricular extrasystole.


Ventricular Tachycardia Antiarrhythmic Drug Holter Monitoring Ventricular Extrasystole Paroxysmal Supraventricular Tachycardia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    R. Vilhelmsen, S. A. Mortensen, and E. Sandøe, Diagnostic fallacies and drug management in Prinzmetal’s variant angina, in: “Myocardial Revascularization. Medical and Surgical Advances in Coronary Disease,” D. T. Mason, J. J. Collins, Jr. eds., Yorke Medical Books, New York, N.Y. (1981)Google Scholar
  2. 2.
    B. Sigurd, M. Suenson, A. Wennevold, and E. Sandøe, Means of management of the long Q-T syndrome, in “Management of Ventricular Tachycardia — Role of Mexiletine,” E. Sandøe, D. G. Julian, and J. W. Bell, eds., Excerpta Medica, Amsterdam Oxford (1978).Google Scholar
  3. 3.
    A. Wennevold, and E. Sandøe, 6–14 years’ beta-blockade in three children with paroxysmal ventricular fibrillation, in: “Management of Ventricular Tachycardia — Role of Mexiletine,” E. Sandøe D. G. Julian, and J. W. Bell, eds., Excerpta Medica, Amerster-dam — Oxford (1978).Google Scholar
  4. 4.
    W. A. Pocock, and J. B. Barlow, Postexercise arrhythmias in the billowing posterior mitral leaflet syndrome, Am. Heart J. 80:740 (1970)PubMedCrossRefGoogle Scholar
  5. 5.
    E. Gymoese, E. Skovlund, and E. Sandøe, Paroxysms of ventricular tachycardia provoked by auditory stimuli in Romano-Wards syndrome, Abstract, Acta med. Scand., Suppl. 651:29 (1981).Google Scholar
  6. 6.
    R. Gillis, and J. A. Quest, The role of the nervous system in the cardiovascular effects of digitalis, Pharmacol. Rev. 31:19 (1980).Google Scholar
  7. 7.
    B. Surawicz, Intracardiac extrastimulation studies: how to? where? by whom? — Editorial, Circulation 65:428(1982).Google Scholar
  8. 8.
    R. W. F. Campbell, M. R. Nicholson, and D. G. Julian, Ventricular tachycardia — management with encainide, Abstract, Europ. Heart J., (Suppl. A)2:185 (1981).Google Scholar
  9. 9.
    R. L. Rinkenberger, E. N. Prystowsky, W. M. Jackman, G. V. Naccarelli, J. J. Heger, and D. P. Zipes, Drug conversion of nonsustained ventricular tachycardia to sustained ventricular tachycardia during serial electrophysiologic studies: Identification of drugs that exacerbate tachycardia and potential mechanisms, Am Heart J. 2:178 (1982).Google Scholar
  10. 10.
    J. J. Heger, E. N. Prystowsky, W. M. Jackman, G. V. Naccarelli, K. A. Warfel, R. L. Rinkenberger, and D. P. Zipes, Amiodarone: Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation, New Engl. J. Med.10: 539 (1981).CrossRefGoogle Scholar
  11. 11.
    J. Morganroth, E. L. Michelson, L. N. Horowitz, M. E. Josephson, A. S. Pearlman, and W. B. Dunkman, Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency, Circulation 3:408 (1978).CrossRefGoogle Scholar
  12. 12.
    M. Sami, H. Kraemer, D. C. Harrison, N. Houston, C. Shimasaki, R. F. DeBusk, A new method for evaluating antiarrhythmic drug efficacy, Circulation 62:1172 (1980).PubMedCrossRefGoogle Scholar
  13. 13.
    B. Sigurd, J. Fischer Hansen, K. Mellemgaard, and J. Damgaard Andersen, Comparative effects of tocainide and procainamide in the treatment of ventricular ectopic complexes, in: “Workshop on Tocainide — Conference Held in Copenhagen, November 1979,” A. Pottage, and L. Tyden, eds., Hässle, Mölndal, Sweden (1981).Google Scholar
  14. 14.
    J. P. Van Durme, M. Bogaert, I. Bekaert, D. De Clercq, and E. Moerman, Comparison of the antidysrhythmic efficacy of atenolol, disopyramide, mexiletine and placebo, in: “Management of Ventricular Tachycardia — Role of Mexiletine,” E. Sandøe, D. G. Julian, and J. W. Bell, eds., Excerpta Medica, Amsterdam — Oxford (1978).Google Scholar
  15. 15.
    M. A. Warnowicz, and P. Denes, Chronic ventricular arrhythmias: Comparative drug effectiveness and toxicity, Prog. Cardiovasc.Dis. 23:225 (1980).PubMedCrossRefGoogle Scholar
  16. 16.
    M. B. Rosenbaum, P. A. Chiale, M. S. Halpern, G. J. Nau, J. Przybylski, R. J. Levi, J. O. Lazzari, M. V. Elizari, Clinical efficacy of amiodarone as an antiarrhythmic agent, Am. J. Cardiolog. 38:934 (1976).CrossRefGoogle Scholar
  17. 17.
    M. W. Millar Craig, and E. B. Rafferty, A double-blind trial of disopyramide, procaineamide and digoxin in paroxysmal supraventricular tachycardia, Clin. Cardiol. 2:179 (1980).Google Scholar
  18. 18.
    K. Midtbø), Verapamil in the prophylactic treatment of paroxysmal supraventricular tachycardia, Curr. Ther. Res. (1981).Google Scholar
  19. 19.
    E. Damgaard Andersen, J. Ramsøe Jacobsen, E. Sandøe, J. Videbæk, and A Wennevold, Paroxysmal tachycardia in infancy and childhood: A review and a long-term follow-up study, Acta Pæ diat. Scand. 62:341 (1973).CrossRefGoogle Scholar
  20. 20.
    T. D. Sellers, T. M. Bashore, and J. J. Gallagher, Digitalis in the pre-excitation syndrome, Circulation 56:260 (1977).PubMedCrossRefGoogle Scholar
  21. 21.
    G. S. May, K. A. Eberlein, C. D. Furberg, E. R. Passamani, and D. L. DeMets, Secondary prevention after myocardial infarction: A review of long-term trials, Prog. Cardiovasc. Dis 24: (1982).Google Scholar
  22. 22.
    J. T. Bigger, Jr., The quinidine — digoxin interaction — Editorial review, Intnl. J. Cardiol. 1:109 (1981).CrossRefGoogle Scholar
  23. 23.
    J. O. Moysey, N. S. V. Jaggarao, E. N. Grundy, D. A. Chamberlain, Amiodarone increases plasma digoxin concentration — short reports, Brit. Med. J. 282: 272 (1981).CrossRefGoogle Scholar
  24. 24.
    K. E. Pedersen, A. Dorph-Pedersen. S. Hvidt, N. A. Klitgaard, and F. Nielsen-Kidsk, Digoxin-verapamil interaction, Clin. Pharmacol. Therap.30: 311 (1981).CrossRefGoogle Scholar
  25. 25.
    V. Velebit, P. J. Podrid, I. B. Graboys, and B. Lown. Aggravation of ventricular arrhythmia by antiarrhythmic drugs Abstract, Am. J. Cardiol. 43:359 (1979).Google Scholar
  26. 26.
    P. Denes, A. Gabster, and S. K. Huang, Clinical, electrocardiographic and follow-up observations in patients having ventricular fibrillation during Holter monitoring. Role of quinidine therapy, Am. J. Cardiol. 48:9 (1981).PubMedCrossRefGoogle Scholar
  27. 27.
    R. W. Koster, H. J. J. Wellens, Quinidine-induced ventricular flutter and fibrillation without digitalis therapy, Am. J. Cardiol. 38:521 (1976).CrossRefGoogle Scholar
  28. 28.
    G. Ellrodt, B. N. Singh, Adverse effects of disopyramide (Norpace) Toxic interactions with other antiarrhythmic agents, Clin Pharmacol. Critical Care 9:469 (1980).Google Scholar
  29. 29.
    D. Scagliotti, B. Strasberg, H. A. Hai, R. Kehoe, K. Rosen, Aprindine-induced pholymorphous ventricular tachycardia, Am. J. Cardiol.49:1297 (1982).PubMedCrossRefGoogle Scholar
  30. 30.
    M. Laakso, P. J. Pentikäinen, K. Pyörälä, and P. J. Neuvonen, Prolongation of the QT interval caused by sotalol — possible association with ventricular tachyarrhythmias, Europ. Heart J. 2: 353 (1981).Google Scholar
  31. 31.
    J. M. McComb, K. R. Logan, M. M. Khan, J. S. Geddes, and A. A. J. Adgey, Amiodarone-induced ventricular fibrillation, Europ. J. Cardiol. 11:381 (1980).Google Scholar
  32. 32.
    P. J. Podrid, A. Schoeneberger, and B. Lown, Congestive heart failure caused by oral disopyramide, New Engl. J. Med. 302: 614 (1980).PubMedCrossRefGoogle Scholar
  33. 33.
    K. Nademanee, J. A. Hendrickson, D. S. Cannom, B. N. Goldreyer, B. N. Singh, Control of refractory life-threatening ventricular tachyarrhythmias by amiodarone, Am. Heart J. 101:759 (1981).PubMedCrossRefGoogle Scholar
  34. 34.
    W. J. McKenna, L. Harris, G. Perez, D. M. Krikler, C. Oakley, J. F. Goodwin, Arrhythmia in hypertrophic cardiomyopathy. II Comparison of amiodarone and verapamil in treatment, Brit. Heart J. 46:173 (1981).PubMedCrossRefGoogle Scholar
  35. 35.
    M. B. Rosenbaum, P. A. Chiale, D. Ryba, M. V. Elizari, Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride — Reports on therapy, Am. J. Cardiol. 34:215 (1974).PubMedCrossRefGoogle Scholar
  36. 36.
    E. Damgaard Andersen, Long-term antiarrhythmic therapy with amiodarone. High prevalence of thyrotoxicosis (11%), Abstract, Europ. Heart J., (Suppl. A) 2:199Google Scholar
  37. 37.
    M. H. Jonckheer, Amiodarone and the thyroid gland. A review, Cardiologica 36:199 (1981).Google Scholar
  38. 38.
    S. M. Sobol, and L. Rakita, Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: A possible complication of a new antiarrhythmic drug, Circulation 65:819 (1982).PubMedCrossRefGoogle Scholar
  39. 39.
    E. M. Vaughan Williams, Electrophysiological basis for a rational approach to antiarrhythmic drug therapy, Adv. Drug Res. 9:69 (1974).PubMedGoogle Scholar
  40. 40.
    P. Coumel, P. Attuel, and J. F Leclercq, The role of calcium antagonists in ventricular arrhythmias, in: “Calcium Antagonism in Cardiovascular Therapy: Experience with Verapamil.” Proceedings of International Symposium, Florence October 1980, A. Zanchetti, and D. M. Krikler eds., Excerpta Medica. Amsterdam (1981).Google Scholar
  41. 41.
    H. J. J. Wellens, A. Vermeulen, and D. Durrer, Ventricular fibrillation occurring on arousal from sleep by auditory stimuli, Circulation 46: 661 (1972).PubMedCrossRefGoogle Scholar
  42. 42.
    J. L. Cox, Indications and results of surgery, in: “Proceedings of Symposium on Chronic Antiarrhythmic Therapy, Gent 1982,” J. P. Van Durme, and M. G. Bogaert eds., Astra, Mölndal, Sweden (In press).Google Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • Erik Sandϕe
    • 1
  • Ellen Damgaard Andersen
    • 1
  • Jens Damgaard Andersen
    • 1
  • Bjarne Sigurd
    • 1
  1. 1.Medical Department BRigshospitalet, CopenhagenDenmark

Personalised recommendations